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1. Introduction
Endovascular repair is becoming the milestone of treatment for aneurysmal disease of the
abdominal aorta, evolving over time as an attractive alternative to open repair, especially for
elderly and high risk patients.
Since the introduction of endovascular aneurysm repair (EVAR) 20 years ago [1] many suc‐
cessful early results have been achieved with this treatment, but mid-term and long-term
durability of the endograft devices that have been used remains questionable [2-5].
Endovascular techniques and technical material have improved from the initial devices and
have permitted the extension of the treatment to more and more complex anatomies.
However, sustained survival benefits have not been proven because nowadays only mid-
term results after EVAR have been reported, and additional procedures were required in
many patients.
Late failure of endovascular repair secondary to endoleaks, endotension and sac enlarge‐
ment, stentgraft migration, tear and fracture or infection continues to be a persistent prob‐
lem that can result in delayed aneurysm rupture [5-8].
Large cohorts of studies have reported rates of abdominal aortic aneurysm (AAA) rupture
after EVAR ranging from 0.5 to 1.2% per patient per year [9-14]. Lifetime risks are even
higher because most patients live for several years after the procedure [15].
Therefore, although several randomized trials have shown lower perioperative morbidity
and mortality after EVAR compared with open repair [16-19], mid and long-term complica‐
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tion, most of which represented by endoleaks, are quite frequent after EVAR and the risk of
late rupture persists.
Availability of new generation devices, strict patient selection and respect of correct mor‐
phological criteria are crucial to obtain good outomes of EVAR, reducing the risk of postop‐
erative complications, including delayed rupture.
2. Materials and methods
In our own series, involving one University Hospital and four Regional Hospitals, between
January 2004 and December 2011, a total of 1500 patients underwent endovascular repair of
AAA with a variety of commercially available stent grafts.
Emergent aortomonoiliac EVAR and crossover bypass was performed in 90 (5%) patients
with ruptured AAA, while the remaining patients received elective EVAR with bifurcated
(n=1020, 72.3%) or aortomonoiliac endograft with crossover bypass (n=390, 27.7%).
The mean postoperative follow-up was 30 months (range 6-72). The imaging protocol in‐
cluded angiogrphic computer tomography (angioTC) performed at intervals of 1, 3, 6, 12
months after the procedure and annually thereafter.
Aneurysm rupture was defined as an extravasation of blood outside the aortic wall, docu‐
mented at angioCT.
3. Results
During the follow-up 22 patients (1.46%) presented with late aneurysm rupture after EVAR.
These results are in consonance with the data avaiable in literature [20-24].
There were no statistical differences between patients undergoing emergent or elective
EVAR and among patients undergoing bifurcated or aortomonoiliac endografting.
Causes of rupture include endoleaks in 51.3% of cases (35% type I, 15.3% type II, 0% type III
and IV), while in 49.7% of cases the cause remained undetermined.
Most of the described AAA ruptures occurred within 1-3 years after endovascular repair.
The mean time to rupture from the primary EVAR was 20 months. The mean initial aneur‐
ysm diameter was relatively large (62 mm).
All patients arrived alive to treatment. Eight patients had a redo EVAR, while 14 underwent
open repair. Three out of 8 patients (37.5%) died after redo EVAR and 6 out of 14 patients
(42.8%) treated by open repair died during the operation or in the perioperative period.
The incidence of overall mortality after rupture in this experience was 40.9 %.
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4. Discussion
Several studies have demonstrated better peri-operative survival for endovascular over
open repair of AAA, with fewer complications and a shorter recovery period [16-19].
However there are concerns about durability of endovascular repair at long-term when
compared with conventional open treatment. Actually EVAR does not completely eliminate
the risk of late aneurysm rupture and requires more frequent reinterventions to maintain the
exclusion of the aneurysm, including conversion to open repair.
Success of the endovascular treatment depends on the strict selection of the patients, evalu‐
ating specific anatomic characteristics like diameter, lenght and angulation of the aortic neck
as well as iliac morphology.
In a 2010 retrospective study involving 1768 patients undergoing EVAR, Metha et al [25] re‐
ported an incidence of additional secondary procedures of 19.2% during a mean follow-up
period of 34 months (Tab. 1).
Number of patients 1,768
Mean follow-up [SD] 34 Months [30]
Secondary intervention 19.2%
Type II Endoleak 40.1%
Type I/III Endoleak 16.5%
Migration 13.6%
Limb occlusion 7.4%
Other (rupture, device defect, etc.) 8.6%
Table 1. Incidence of secondary procedures after EVAR.
In 2010 the results of the DREAM trial showed a reintervention rate of almost 30% within 6
years [26]. The most frequently reported complications include endograft migration, endo‐
leaks, limb occlusion and rupture.
Endoleak is the Achille’s heel of the EVAR, revealing associations with both early and late
failure of the procedure and is the most common reason for aortic rupture and reinterven‐
tions in the follow up of EVAR.
The incidence of all endoleaks is reported in the major trials of recent years as ranging from
15.6% to 19.8% [17-19].
The endoleaks are classified into five types according to the etiology (Tab. 2) [27].
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Type Origin of the leak
I Inadeguate seal at proximal (Ia) or distal (Ib) end of the graft
II Retrograde flow from the inferior mesenteric artery, lumbar arteries, others collateral vessels of the
aneurysm sac
III Component disconnection (IIIa) or fabric disruption (IIIb)
IV Graft material porosity
V Endotension: increase of the pressare without any visibile evidente of blood in the aneurysm sac
Table 2. Endoleak classification. From: Moll FL, Powell JT, Fraedrich G, et al. Management of abdominal aortic
aneurysms clinical practice guidelines of the European society for vascular surgery. Eur J Vasc Endovasc Surg
2011;41(Suppl 1):S1-S58.
One of the most frequent causes of type I endoleak is represented by the aneurysmatic evo‐
lution of the proximal aortic neck. Aortic aneurysmal degeneration can progress over time
to involve the segments chosen at the time of surgery as appropriate landing zones for effec‐
tive sealing. Therefore, late degeneration of the landing zones can lead to endograft migra‐
tion and type I endoleak with sac enlargement.
Some authors have reported a dilatation of the landing zone after EVAR [28]. Possibile ex‐
planations could be the continuous outward radial force of the uncovered portion of the en‐
dograft, in particular in case of high oversizing, or the forces applied in this region during
the implantation of the device.
Type I endoleaks can also occur as a result of stentgraft migration that may originate from
unstable proximal sealing, as a consequence of wrong planning involving oversizing under‐
stimation and lack of graft radial force, especially in case of poor quality of proximal aortic
neck (i.e. short lenght, severe angulation, high calcification and thrombus load).
Severe angulations and tortuosity of the aorta and the iliac arteries usually can also led to
graft migration with possibile type I endoleaks.
Iliac fixation plays an important role in preventing stentgraft migration. Extension of both
iliac limbs to the level of the iliac bifurcation seems to minimize the risk of endograft migra‐
tion, despite suboptimal neck anatomy.
Type III endoleak is caused mainly by a dislocation of two stentgraft components in a mod‐
ular stentgraft system (IIIa), generally due to a shortening of the overlapping zones during
the procedure. Extreme angulation of the neck or iliac segments may also be a contributing
factor. Failure relate to modular disjunction is preventable by ensuring an adequate compo‐
nent overlap during the intervention.
Other causes of type III endoleak are due to a device failure as a consequence of a deficit in
the graft fabric (type IIIb).
Patients with type I and III endoleaks have been identified as being at gratest risk of aneur‐
ysm rupture. Conventional endoleak management consists in prompt repair of type I and III
endoleaks.
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Type IV endoleak is determined by an excessive porosity of the stentgraft that appears in‐
tact. Since these endoleaks may spontaneously seal, their treatment is not recomended.
Type II endoleak is related to retrograde flow via collaterals, mostly lumbar arteries, hypo‐
gastric arteries, inferior mesenteric artery. Although type II endoleak is considered benign,
this persistent flow could prevent thrombosis of the aneurysm sac, resulting in a potential
risk of continued aneurysm expansion and possibile rupture.
Many early type II endoleak are transient and will resolve spontaneously within six months,
but a small minority of patients with untreated endoleak type II may suffer from aneurysm
rupture. The treatment of type II endoleaks should considered when it suddenly appears
during follow-up or when it persist for more than 6 months without shrinkage of the sac.
Ronsivalle et al [29] have reported the efficacy of the injection of fibrin glue with coils into
the aneurysm sac, in addition to the conventional EVAR protocol. The aim of this procedure
is to induce clotting of the aneurysm sac, thus reducing the risk of type II endoleaks, poten‐
tially leading to late aneurysm rupture.
In our experience, intraoperative intrasac thrombin injection was employed in patients with
AAA at high risk of type II endoleaks (absence or modeste intraluminal thrombus, presence
of inferior mesenteric artery, lumbar arteries, hypogastric or accessory renal arteries). Early
results at follow-up showed a reduction of the incidence of type II endoleak, as well as type
I endoleak, since clotting of the aneurysm sac presumably provides also stability of the en‐
dograft, so preventing migration of the devices.
Although the high incidence of secondary interventions after EVAR decreased significantly
in recent years, largely thanks to devices improvement, the widespread use of the endovas‐
cular treatment often leads surgeons to force the indications to EVAR, even in patients with
unfavorable anatomy.
Endografts placed outside device guidelines were associated with higher aneurysm-related
mortality, reinterventions, graft-related adverse events, indicating that adherence to such
guidelines is a foundamental clinical practice.
5. Data from literature
Data from literature about late aneurysm rupture after EVAR and relative mortality were
collected. Results are summarized in table 3 and compared with our experience.
The EUROSTAR (European Collaborators on stent-graft techniques for aortic aneurysm re‐
pair) registry [4], established in 1996, collected data on the outcome of treatment of patients
with infrarenal AAA treated by EVAR, with the purpose to evaluate incidence and risk fac‐
tors of late rupture, conversion and death. In this large study 2464 patients have been enrol‐
led, with a median follow-up of 12.14 months. Thirteen patients sustained confirmed
aneurysm rupture 30 days or more after operation. One rupture occurred in the periopera‐
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tive period (within 30 days). Only those patients with clear signs of rupture (derived from
the findings at operation, CT images or autopsy results) were included in the study. Patients
who died suddenly before a precise diagnosis could be confirmed (10 patients) were not in‐
cluded. Details of the patients with proved rupture are shown in table 4.
Peak incidence of rupture occurred 18 months after the intervention (range 0-24 months).
The annual cumulative rate of rupture approximated to 1% per year (1.4% in the first year,
0.6% in the second year). Twelve patients (85.7%) underwent emergency open surgery, five
of whom (41.6%) survived. There were no survivors between the two patients who were not
subject to an emergency operation. The overall death rate of late ( > 30 days) aneurysm rup‐
ture after EVAR was 69.2% (9/13) of the patients.
Proximal type I endoleak, midgraft (type III) endoleak, migration and postoperative kinking
of the endograft were proved to be relevant risk factors for rupture. Type II endoleak, distal
type I endoleak, endograft stenosis ana thrombosis were present but statistically not signifi‐
cant (table 5).
Persistent endoleak as indicator of failure of the treatment was based on the assumption that
the endoleak itself was the cause of the continued expansion and the eventual rupture of the
aneurysm sac after EVAR.
Nevertheless, at last three of 10 patients who died suddenly of unknown causes had an
aneurysm of a maximum diameter greater than six centimeters before their death. Although
there may have been cardiac malfunction or other postoperative causes, rupture was likely
to account for some of these 10 deaths.
Study (year) N. late rupture(%)
Overall mortality
(%)
N. patients undergoing
surgery
Mortality after
surgery
Harris (2000) [4] 13/ 2464 (0.52) 8/13 (61.5) 11/13 (84.6) 6/11 (54.54)
Bernhard (2002) [30] 7/3946 (0.17) 4/7 (57) 6/7 (85.7) 3/6 (50)
Hobo (2008) [20]
(1.7) (4.5)
NR NR
(4.5) (*) (7.4) (*)
Szmidt (2007) [21] 3/445 (0.67) 0 0 0
Wyss (2010) [22] 22/848 (2.59) 15/22 (68.18) 8/22 (36.36) 1/8 (12.5)
Koole (2011) [23] 26/6337 (0.41) NR (62) NR NR
Metha (2011) [24] 27/1768 (1.52) 4/27 (14.81) 26/27 (96.3) 3/26 (11.5)
Our experience (2011) 22/1500 (1.46) 9/22 (40.9) 22/22 (100) 9/22 (40.9)
(*) presence of concomitant iliac aneurysm
N.R. not reported
Table 3. Incidence and mortality of delayed aneurusysm rupture after EVAR.
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Moreover, EUROSTAR experience demonstrates that the overall death rate of 64.3% (9/14)
for AAA rupture after EVAR is not inferior than the usual expectation of mortality after rup‐
tured AAA repair, as previously reported [31].
The analysis of risk factors for late rupture in the EUROSTAR study confirms the impor‐
tance of proximal fixation site endoleak, while distal endoleaks seem to have a more be‐
nign impact, possibly because of the lower pressure or endotension in the aneurysm sac.
Moreover, results of this study seem to confirm that type II endoleak is less important as
regard to aneurysm rupture,  most of them resolving spontaneously.  However,  prudence
is  mandatory because of  uncertainty regarding the accuracy of  diagnosis  of  these endo‐
leaks.  Kinking of  the endovascular  devices  could also be responsible  of  the sac rupture
as well as stent migration.
Even if the death rate associated with all operations for conversion repair in the EUROSTAR
experience was 24.4%, surgeons must realized that the risk of delayed rupture is greater
than the risk of conversion.
In 2008 an outcome analysis of EUROSTAR experience compared results following EVAR in
patients affected by AAA with (group II) and without (group I) concomitant iliac artery
Serial no. Time since operation(mo)
Intervention on
rupture Device Outcome (at 30 d)
1 18 Conversion Vanguard* Death
2 24 Conversion Vanguard* Death
3 3 Conversion AneuRx Death
4 12 Conversion Stentor* Survived
5 18 Conversion Stentor* Survived
6 6 Conversion Vanguard* Death
7 18 Conversion Vanguard* Survived
8 18 Nil Vanguard* Death
9 6 Conversion Vanguard* Survived
10 24 Conversion Vanguard* Death
11 3 Nil Talent Death
12 18 Conversion Vanguard* Death
13 24 Conversion Vanguard* Survived
14† 0 Conversion Talent Death
*Discontinued model devices.
†One rupture within 30 days of endovascular repair
From: Harris PL, Vallabhaneni SR, Desgranges P, et al. Incidence and risk factors of late rupture, conversion, and death
after endovascular repair of infrarenal aortic aneurysms: the EUROSTAR experience. European collaborators on stent/
graft techniques for aortic aneurysm repair. J VascSurg 2000;32:739-49
Table 4. Details of patients with a proved rupture of the treated aneurysm.
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aneurysm [26]. Mortality rates was obtained from the Registry database for the period from
October 1996 to November 2006. Group II included more patients classified as ASA III-IV,
who were considered more frequently unfit for open surgery, with larger-diameter aneur‐
ysms and infrarenal necks, an increased incidence of internal iliac artery occlusion and
greater angulation of the aortic neck and iliac artery (Tab. 3).
The 5-year cumulative incidence of distal type I endoleak was higher in group II (9.1%) than
in group I (4.3%) as well as the 5-year cumulative incidence of aneurysm rupture (4.5% in
group II versus 1.7% in group I; p = 0.042) (Fig. 1).
Nevertheless, between the two study groups was not found an aneurysm-related mortality
rate significantly different (4.5% in group I and 7.4% in group II). However, this rate could
be underestimated because the cause of death was unknown or undefined in a significante
number of patients.
Adverse factor
Free from
rupture and
adverse factor
(n)
Rupture with
adverse factor
(n)
Rupture free
from adverse
factor (n)
Adverse factor
free from
rupture (n)
P value
Relative
hazard ratio
(95% CI)
Proximal type I
endoleak 2250 3 10 62 .0001
7.59
(2.09-27.62)
Midgraft (type III)
endoleak 2224 5 8 88 .0001
8.95
(2.92-27.52)
Stent-graft
migration 2248 3 10 64 .0001
4.53
(1.24-16.66)
Kinked endograft 2216 3 10 96 .0001 3.13(1.40-11.49)
Type II endoleak* 2106 2 11 206 .415*
Distal type I
endoleak* 2177 1 12 135 .776*
Endograft stenosis* 2275 0 13 37 .646*
Thrombosed
endograft* 2235 0 13 77 .503*
*Statistically not significant.
From: Harris PL, Vallabhaneni SR, Desgranges P, et al. Incidence and risk factors of late rupture, conversion, and death
after endovascular repair of infrarenal aortic aneurysms: the EUROSTAR experience. European collaborators on stent/
graft techniques for aortic aneurysm repair. J VascSurg 2000;32:739-49
Table 5. Risk factors for late rupture and their incidence after endovascular repair.
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In this study distal type I endoleaks was strongly associated (p < 0.0001) with the presence
of concomitant iliac aneurysms. The greater incidence of these endoleaks appears to be due
to a more difficult achievement of an adequate distal seal and fixation of the endograft in the
external iliac artery, which is frequently tortuous, angulated or diseased in this area. Distal
type I endoleak is probably the cause of the higher incidence of aneurysm rupture observed
in these patients.
In 2007 Szmidt et al [21] presented their experience with 445 patients undergoing EVAR
between 1998  and 2006.  The  authors  reported  three  (0.67%)  late  aneurysm ruptures.  In
all  cases the cause was type I  endoleak, due to graft  migration in two cases and aneur‐
ysm lengthening in the remaining case.  All  the patients  received open aneurysmectomy
without any major complications.
Group I (n=6286) Group II (n=1268) p*
Mesasurements
Infrarenal neck diameter, mm 24.1 +/- 3.3 24.5+/-3.4 <0.001
Infrarenal neck length, mm 26.8+/-11.5 27.7+/-12.6 NS
Maximum aneurysm diameter,
mm 60.7+/-10.4 62.3+/-11.2 <0.0001
Common iliac artery, mm 14.8+/-4.7 25.9+/-13.2 <0.0001
Occlusion
Common or external iliac artery 109 (1.7%) 23 (1.8%) NS
Hypogastric artery 329 (5.2%) 144 (11.4%) <0.0001
Angulation
Aortic neck 1529 (24.3%) 390 (30.8%) <0.0001
Aneurysm 776 (11.7%) 160 (10.9%) NS
Iliac artery 2632 (41.9%) 612 (48.3%) <0.0001
Continuous data are presented as means +/- standard deviation; categorical data are given as counts (percentages).
NS: not significant.
* Univariate analysis.
From: Hobo R, Sybrandy JE, Harris P, Buth J. Endovascular repair of abdominal aortic aneurysms with concomitant iliac
artery aneurysm. Outcome analysis of the EUROSTAR experience.J EndovascTher. 2008;15:12-22
Table 6. Aneurysm anatomy of 7554 AAA patients undergoing Endovascular Aneurysm Repair.
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Figure 1. Freedom from aneurysm rupture. From: Hobo R, Sybrandy JE, Harris P, Buth J. Endovascular repair of abdomi‐
nal aortic aneurysms with concomitant iliac artery aneurysm. Outcome analysis of the EUROSTAR experience.J Endo‐
vascTher. 2008;15:12-22
However, the late rupture rate in this series is probably underestimated because of a limited
follow-up period (mean 30 months) and the dropout of a considerable number of patients.
In a review published in 2009, Schlosser et al [32] identified 270 patients with AAA rupture
after EVAR, most of whom occurred within 2-3 years after the operation (Fig. 2).
Figure 2. Patients with AAA rupture after aneurysm repair by publication date. From: Schlösser FJV, Gusberg RJ, Dar‐
dik A, Lin PH, Verhagen HJM, Moll FL and Muhs BE. Aneurysm rupture after EVAR: can the ultimate failure be predict‐
ed? Eur J VascEndovascSurg 37(1):15-22 (2009).
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The main cause of rupture was reported for 235 of the 270 patients. Endoleaks were reported
in 160 patients (57 type IA, 31 type IB, 23 type II, 26 type III, 0 type IV, 9 endotension, 14 not
specified), graft migration in 41, graft disconnection in 11 and infection in 6.
Late ruptures occurred in 164 patients. The mean time interval between the initial procedure
and subsequent AAA rupture was 24 +/- 18 months (range 2-96, median 20). 155 out of 202
reported moments of rupture occurred within 27 months after EVAR and their incidence
considerably reduced thereafter.
The mean time interval did not differ between men and women in 71 patients in which in‐
formation about gender and time interval was available. Mean initial AAA diameter was
relatively large (65mm).
In 82 patients information about both moments of rupture and AAA diameter was available.
Patients with an initial AAA diameter above the mean (> 65mm) had a shorter time interval
between EVAR and AAA rupture than patients with smaller-diameters AAA, although this
difference was not significant.
The course of AAA diameter during follow-up was described in 101 patients. Growth of the
AAA sac occurred in 36, any changes in 39 and shrinkage in 26 patients.
In 41 patients no abnormalities requiring reintervention were found during the follow-up: in
35 no abnormalities (absence of endoleak, stent fractures, migration, graft angulation, inse‐
cure fixation, signs of inflammation and sac enlargement) were found at all. In another 6 pa‐
tients only a small type II endoleak was found and the AAA diameter was stable.
Fifty-six of all patients presented an endoleak during the most recent follow up visits before
the rupture occur, 6 of whom were small type II endoleaks without sac enlargement. Other
abnormal findings included wire fractures, graft migration or severe graft angulation in 11,
insecure fixation in 5, AAA sac inflammation in 1, while AAA rupture itself was diagnosed
during a regular follow-up visit in 5 patients.
160 patients underwent open conversion and 26 sustained a redo-EVAR. In 24 patients no
repair was performed at all and for 60 no data were available.
AAA ruptures  were  fatal  in  about  half  of  the  patients  (119  out  of  231)  for  whom data
about mortality were reported. In patient undergone to endovascular or open repair the
results were slightly better:  a fatal course occurred in 62 of 138 patients that underwent
open conversion and in 7 of 26 patients that were subjected to a redo endovascular rup‐
tured AAA repair.
This study has however some limitations. Because data collection was obtained from the
existing literature, informations about many variables could not been avaiable for all pa‐
tients (e.g.  data about neck diameters at the time of EVAR and time of rupture, year of
repair,  etc.).  Another  disadvantage  is  that  the  determination  of  the  cause  of  aneurysm
rupture was based on the description reported by the authors of the selected articles. Be‐
cause  different  authors  may have  used different  criteria  to  estabilish  causes  of  rupture,
this process may have been relatively subjected. Moreover, in 24 of 270 patients, no pre‐
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cise description about diagnostic examinations was provided and no fatal course was de‐
scribed. Theoretically there may have been a possibility that any of these 24 patients had
a “symptomatic” AAA instead of a ruptured AAA.
Another disadvantage concerns the limited follow-up period of a significant number of pa‐
tients, that may partially explain the relatively high number of AAA ruptures in the first 2-3
years after EVAR reported in this study. Indeed, ruptures after 3 years may be underrepre‐
sented due to movement of patients to other institutions or due to mortality.
It is interesting to note that a strong association between lager-diameter aneurysm and in‐
creased risk of rupture after EVAR has been described by the EUROSTAR registry, Lifeline
registry and AneuRx trail [9-15, 33-38].
Increased rupture risk in patients with persistent type II endoleak was reported by Johns et
al [39]. Female gender seems to be associated with an increased risk of rupture too [12,13].
Because relatively many ruptures occur between the follow up visits at one and two years
after EVAR, an additional follow-up after 18 months may possibly reduce the AAA rupture
rate. This may be especially important for patients with early rupture, such as patients with
larger AAA diameters, endoleaks or graft migration.
Data from the EVAR trials [16, 40] were analyzed by Wyss et al [22] in order to asses factors
associated with AAA rupture after EVAR or open repair. There were no ruptures in the 594
patients undergoing open aneurysmectomy, during a follow-up with average duration of
5.3 years. On the other hand, out of a total of 848 elective EVARs, 27 ruptures occurred dur‐
ing an average follow-up period of 4.8 years (25 in EVAR trial 1 and 2 in EVAR trial 2), with
a rate of rupture of 0.8 and 0.2 per 100 patients per year, respectively.
The ruptures were divided into three groups. Group A contains 5 (18.5%) ruptures that oc‐
curred in the perioperative period (within 30 days). Group B included 5 (18.5%) patients
who sustained rupture more than 30 days after the intervention, without prior complication
or signs of failed endovascular treatment. Four of the 5 patients died within 30 days of the
rupture. One patient sustained the rupture at home on day 32 and no post-procedural imag‐
ing was performed before discharge. Three patients underwent a normal follow-up CT scan
within 2 months before rupture, all showing sac shrinkage with any abnormal findings. An‐
other patient showed sac shrinkage and no complications during the first 2 years but he
missed the three years follow-up scan. Thus, even if a predischarge scan had been proposed
as part of the EVAR trial protocol, three ruptures remained unexplained, despite optimal
protocol had been followed.
Group C included 17 (63%) patients with late ruptures with prior complications. Eleven of
these patients died within 30 days of the rupture. Sac enlargement had been observed in 15
of 17 patients, with documented endoleaks in 12 of these 15 patients. In the remaining 2 pa‐
tients, without sac expansion, one sustained graft migration and one presented an endoleak
of undfinited origin. Three cases had a type II endoleak as previously described complica‐
tions. All these patients presented concomitant sac enlargement before rupture. Twelve pa‐
tients with a prior complication underwent a secondary intervention before rupture.
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Surgical repair was performed in 12 out of 27 patients who experienced aneurysm rupture,
with an overall surviving rate of 75%. Seven patients (4 in group A and 3 in group C) under‐
went open repair, 5 of whom survived more than 30 days, while endovascular treatment
was performed in 5 patients (1 in group B and 4 in group C), 4 of whom survived more than
30 days. The remaining 15 patients died before aneurysm repair could be attempted.
In this study there was a significant association between rupture and previous detection of
complications (type I endoleak, type II endoleak with sac expansion, type III endoleak with
migration or kinking of the endograft) and no significant difference in rupture rate between
the different kinds of endoprosthesis employed (Cook Zenith, Medtronic Talent, Gore Ex‐
cluder, others). A risk of rupture doubling for each centimeter increase of top neck diameter
was suspected. The analysis also suggested that age was an influential factor, with a risk of
rupture increasing with age.
Bernhard et al [30] showed their experience with aneurysm rupture after deployment of
Guidant/EVT endograft and reviewed previously reported cases with others devices. The
authors collected 47 cases of ruptured AAA after EVAR from 1993 to 2000, seven of whom
occurred after the use of Guidant/EVT devices. Causes of rupture are listed in table 7.
Type and source of endoleak No. of patients
Type I endoleak 27
Proximal attachment 12†
Distal attachment 14
Aorta 10†
Iliac 4
Site not reported 1
Type II endoleak 2
Type III endoleak 11
Modular disconnection 5 (2‡)
Stent erosion through fabric 1
Details not reported 5
Leak present, source not reported 4
†Three patients met criteria for endotension (AAA enlargement in absence of detectable endoleak before AAA rup‐
ture). One had proximal leak shown at surgery. Another was classified as proximal leak on basis of known migration at
proximal neck; however, no post rupture CT scan, surgery, or autopsy was found to verify this presumption. A third
had initial increase in AAA diameter that remained stabile until rupture from distal aortic endoleak. Endoleak was rec‐
ognized in retrospect.
‡Associated fabric tear in Dacron graft wall and disruption of sutures attaching it to metal frame.
From: Bernhard VM, Mitchell RS, Matsumura JS, Brewster DC, Decker M, Lamparello P, Raithel D, Collin J. Ruptured ab‐
dominal aortic aneurysm after endovascular repair.J VascSurg 2002;35:1155-62.
Table 7. Causes of rupture (n = 44 of 47 patients; cause not reported in three patients).
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Mortality rate in these cases was 57% (4/7) overall and 50% for surgical repair (3/6). In the 40
additional ruptures related to other devices, for a total of 47, the overall mortality rate for
the combined series was 50%, with an operative mortality rate of 41%.
Ruptures after implantation of Guidant/EVT occurred in patients with tube grafts and all
were a consequence of a type I endoleak developed at the distal aortic attachment site. Five
occurred in 93 patients followed for a mean of 41.8 months and treated with first-generation
tube graft, which were prone to develop attachment mechanism fractures. The remaining
two ruptures occurred in the subgroup of 166 patients who received second-generation tube
endografts.
No ruptures were reported in patients who received bifurcated or unilateral iliac devices,
over a mean follow-up of 37.5 months.
Factors contributing to endoleak and postoperative rupture are reported in table 8.
Contributing factors No. of patients with contributing factors
Loss of endograft integrity 16
Endograft migration 10
Severe angulation of proximal aortic neck 6
Dilatation of distal aortic neck after implant 5
Patient refused intervention for endoleak 5
Delayed or discontinued follow-up 4*
Surgical conversion delayed 4
Poor patient selection 3
Wide distal neck lined with clot 2
Iliac artery attachment site too wide 1
Short proximal aortic neck 2
Error in deployment technique 2
Stiff graft body design 2
Proximal neck thrombus 1
Short distal aortic neck 1
Low graft implantation 1
AAA shrinkage 1
Total 63
*Two patients did not have CT scan for 11 months, although this delay waswithin prescribed time frame of investiga‐
tional protocol.
Multiple contributing factors were reported in several patients; two in sevenpatients, three in seven patients, and five
in two patients.
From: Bernhard VM, Mitchell RS, Matsumura JS, Brewster DC, Decker M, Lamparello P, Raithel D, Collin J. Ruptured ab‐
dominal aortic aneurysm after endovascular repair.J VascSurg 2002;35:1155-62.
Table 8. Factors contributing to endoleak and postoperative rupture (information reported for 34 of 47 patients).
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In this investigation 9 out of 19 patients in which pre-rupture imaging was available suf‐
fered aneurysm rupture despite the absence of aneurysm enlargement. However most of
these patients showed other abnormalities that could underlie a rupture.
Authors conclude that (1) the use of tube endografts should be restricted to the rare cases
with ideal anatomy, no other alternatives and at high risk for open repair; (2) primary endo‐
leaks have a tendency to early rupture, which entails the need to their treatment without de‐
lay; (3) prevention could be possible in some patients if there had been application of strict
anatomic criteria for exclusion and rigorous adherence to prestabilited follow-up protocol;
(4) outcomes of delayed aneurysm rupture after EVAR are similar to those expected for pa‐
tients without prior endografts.
A study evaluating the AAA annual rupture risk in patients without detectable endoleak af‐
ter EVAR (endotension) has been published in 2011 by Koole et al [23]. The basis for this
analysis was 6337 patients who were enrolled prospectively in the EUROSTAR database be‐
tween 1996 and 2006. Perioperative mortality rate of conversion to open AAA repair in these
patients was also assessed.
In this study aneurysm enlargement was defined as a diameter increase >/= 8 mm relative to
the preoperative diameter measurements. Patients were divided into three groups depend‐
ing on the degree of shrinkage or enlargement of the aneurysm sac. Group A included pa‐
tients with > 8 mm aneurysm shrinkage, group B consisted of patients with </= 8 mm
shrinkage to </= 8 mm enlargement and group C presented an aneurysm enlargement of > 8
mm. Ruptures occurred in 26 patients: 3/691 (0.4%) patients in group A, 14/5307 (0.32%) pa‐
tients in group B and 9/339 (2.6%) patients in group C. The median interval to aneurysm
rupture after EVAR was 48 months and the mortality rate from rupture was 62%.
The annual rate of rupture in group C was < 1% in the first 4 years but increased to 7.5% up
to 13.6% in the years thereafter (table 9), thus suggesting the need for conversion. The mor‐
tality rate of elective conversions to open repair was 6.0%. A significant higher conversion
rate was observed in group C, compared with group A and B.
Year of FU Combined FUa (years) Ruptures (n) Annual rupture rate (%)
1 264 0 0
2 206 1 0.5
3 149 0 0
4 102 0 0
5 67 5 7.5
6 37 0 0
7 22 3 1 3.6
FU, Follow-up; aCombined FU years were calculated for each interval.
From: Koole D, Moll FL, Buth J et al. Annual rupture risk of abdominal aortic aneurysm enlargement without detectable
endoleak after endovascular abdominal aortic repair. J VascSurg 2011Dec;54(6):1614-22.
Table 9. An overview of the different annual rupture risks in group C.
Delayed Aneurysm Rupture After EVAR
http://dx.doi.org/10.5772/53415
141
The  authors  confirmed  the  role  of  aneurysm  enlargement  without  detectable  endoleak
as an independent factor for conversion.  Conventional  CT angiography visualizing low-
flow  endoleaks  with  a  blood-pool  contrast  agent,  dynamic  electrocardiographically  gat‐
ed  CT  angiography  or  MR  angiography  are  suggested  to  possibly  improve  the
sensitivity for detecting endoleaks [41-42],  thus potentially resulting in a decreased mor‐
tality risk from rupture.
Interestingly in this study a large number of patients were lost to follow-up (50% in group A
and B; 30% in group C). Consequently, a higher number of ruptures and a higher mortality
could be imaginable.
In 2011 Metha et al [24] evaluated the frequency, etiology and outcomes of delayed AAA
rupture following EVAR with the aim to estabilish treatment options that facilitated an im‐
provement in survival. Over a mean follow-up of 29 months (range 14-111 months), 27
(1.5%) out of 1768 patients undergoing elective or emergent EVAR sustained delayed AAA
rupture and required repair by either open surgical conversion or a redo endovascular treat‐
ment. Twenty (74%) patients were lost to follow-up, 17 (63%) patients had type I endoleak
with stentgraft migration, 3 (11%) had type I endoleak without stent graft migration, 5 (19%)
had type II endoleak and two (7%) experienced aneurysm rupture for undetermined causes.
In 15 (55%) patients open surgical repair via retroperitoneal approach was performed, with
partial (8 patients, 53%) or complete (7 patients, 47%) stentgraft explantation and aortoiliac
reconstruction; 11 (41%) patients underwent a redo-EVAR and one (4%) patient refused
treatment and died. Supraceliac aortic clamping was required in three (20%) patients, while
supraceliac occlusion balloon was required in two (18%) patients during EVAR. There were
three (11%) postoperative deaths: two after open conversion and one following EVAR.
Similar mortality rate are reported by other authors [43-45] despite the use of different tech‐
niques (midline vs retroperitoneal approach; supraceliac vs infrarenal vs aortic balloon
clamping; complete or partial removal of the graft).
Interesting to note, in 2011 Venermo et al [46] reported that EVAR may reduce the risk of
rupture and aneurysm-related mortality despite the presence of persisting proximal type I
endoleak, compared to untreated AAA of similar size (11% vs 52%). However this study has
some limitations, as it is retrospective, has small cohorts and the two groups are different
not having being studied over the same time period or in the same geographic location.
Moreover the EVAR group is likely to have received better medical treatment, with tighter
blood pressure control and possible use of statins.
Age and sex are also different in this study while having an important impact on EVAR out‐
come. Suitability for EVAR was found to be associated with a lower rupture rate in unoper‐
ated aneurysms [47]. Therefore, knowing the aortic anatomy in the patients not undergoing
EVAR would have been interesting.
6. Conclusion
In conclusion: the rupture risk for all EVAR patients is thought to be in the order of 0.5 to 1.2
per 100 patients per years [28,37] and it increases with age. Reasonably this is an underesti‐
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mated rupture rate as many patients are lost to follow-up and almost a few could have died
because of aneurysm rupture.
Moreover, no precise description of the performed diagnostic examinations is provided and
no fatal course is described in several publications; consequently, there may have been the
possibility that many patients had a “symptomatic” AAA, instead of a ruptured one.
Relatively many ruptures occur between the follow up visits at 1 and 2 years after EVAR.
An additional follow-up after 18 months may possibly reduce the AAA rupture rate. How‐
ever, it is important to note that rupture can occur even for unknown reasons, despite an
optimal protocol was followed.
The lesson learned when any major complication is found is that the underlying problem
needs to be corrected whenever possible. Particularly, we agree with Chuter’s recommenda‐
tion to treat primary type I endoleaks without delay [48].
Conversion to open repair should be seriously considered, particularly if the complication is
not resolved and the patient is fit enough for this intervention.
However, the risk of this approach will need to be evaluated prospectively, as there is a high
risk of rupture if patients are left untreated and an uncertain mortality risk by conversion to
open repair [4-7,49-52].
Better  stentgraft  durability  and longevity  is  also  required to  further  reduce  this  serious
complication.  Prospective long-term evaluation of  specific  devices will  also be necessary
to determine the reliability of  endograft  exclusion,  as well  increasing using of statins as
protective factors to prevent rupture [47]. Endovascular repair outside manufacturer’s in‐
structions  for  use  is  associated  with  an  unacceptable  risk  of  proximal  type  I  endoleak,
aneurysm-related and all-causes mortality.  Actually tube grafts  should be limited to pa‐
tients with ideal anatomy. In all other cases open surgery or use of fenestrated EVAR in
short necks should be encouraged.
We strongly agree with Veith that until solution of these problems are found, EVAR will re‐
main an imperfect long-term treatment with mortality rate for conversion in the setting of
rupture remaining very high [53].
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